Landscapes / Targets
IL-12
14 drugs act on IL-12, in 22 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs14
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Monoclonal antibody |
Johnson & Johnson (Janssen) · Public JNJ |
Approved | 29 Sep 2027Phase 3 trial completes | ||
| How it works | An antibody | ||||
| Next date | 29 Sep 2027 · Phase 3 trial completes | ||||
| Also tested for | Crohn's Disease, Crohn Disease and 3 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | 30 Dec 2026Phase 1/2 trial completes | |||
| Next date | 30 Dec 2026 · Phase 1/2 trial completes | ||||
| Also tested for | Solid Tumor, Adult | ||||
| Open drug page | |||||
— |
Akeso · Public 9926.HK |
Phase 2 | 28 Feb 2027Phase 1/2 trial completes | ||
| Next date | 28 Feb 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Malignant Solid Tumor, Colorectal Cancer With Hepatic Metastases and 1 more | ||||
| Open drug page | |||||
— |
Phase 1/2 | May 2027Phase 1/2 trial completes | |||
| Next date | May 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
INO-3112not checked |
— |
Phase 1/2 | 31 Dec 2027Phase 1/2 trial completes | ||
| Next date | 31 Dec 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Glioblastoma | ||||
| Open drug page | |||||
— |
Phase 1/2 | Sep 2028Phase 1/2 trial completes | |||
| Next date | Sep 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1/2 | 2 Dec 2028Phase 1/2 trial completes | |||
| Next date | 2 Dec 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Malignant Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 2 | Sep 2029Phase 2 trial completes | |||
| Next date | Sep 2029 · Phase 2 trial completes | ||||
| Also tested for | HCC | ||||
| Open drug page | |||||
— |
Phase 1/2 | 17 Jul 2030Phase 1/2 trial completes | |||
| Next date | 17 Jul 2030 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 2 | — | |||
| Also tested for | Sarcoma, Advanced Intrahepatic Cholangiocarcinoma | ||||
| Open drug page | |||||
— |
Phase 1 | Dec 2026Phase 1 trial completes | |||
| Next date | Dec 2026 · Phase 1 trial completes | ||||
| Also tested for | Advanced Solid Tumor, Metastatic Solid Tumor | ||||
| Open drug page | |||||
— |
Phase 1 | 1 Jan 2027Phase 1 trial completes | |||
| Next date | 1 Jan 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced or Metastatic Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Dec 2027Phase 1 trial completes | |||
| Next date | 30 Dec 2027 · Phase 1 trial completes | ||||
| Also tested for | Head and Neck Cancers- Squamous Cell, Head and Neck Cancer and 11 more | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Advanced Solid Tumor, Soft Tissue Sarcoma Adult | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 13 of 14 drugs. The other 1 is marked “not checked” in the list. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026